• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Optimal Gestational Weight Gain to Reduce Adverse Infant Outcomes

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Wang et al. (JAMA Network Open, 2021) identified optimal gestational weight gain (GWG) ranges associated with reduced risks of infant morbidity and mortality across maternal BMI categories including the different classes of obesity

METHODS:

  • Retrospective cohort study
  • Population
    • US nationwide mother infant pairs between 2011 to 2015
    • Data derived from the US National Center for Health Statistics (NCHS) database
  • Exposures
    • GWG
  • Study design
    • GWG was assessed in 2 kg groups
    • Multivariable logistic regression models were used to link GWG to infant morbidity and mortality and identify optimal GWG ranges for reduced risks of both outcomes
  • Primary outcomes
    • Significant morbidity of the newborn infant
      • Presence of assisted ventilation | Admission to NICU | Surfactant therapy | Antibiotic therapy | Seizures
    • Infant mortality <1 year
      • <1 hour | 1 to 23 hours | 1 to 6 days | 7 to 27 days | 28 to 365 days

RESULTS:

  • 15,759,945 mother-infant dyads
    • Mean (SD) age: 28.1 (5.9) years
    • GWG mean (SD): 14.1 (7.3) kg
  • The mean (SD) GWG decreased with BMI categories (P<0.001)
    • Underweight: 15.7 (6.4) kg
    • Normal weight: 15.4 (6.2) kg
    • Overweight: 14.2 (7.4) kg
    • Obesity class 1: 12.2 (8.0) kg
    • Obesity class 2: 10.3 (8.4) kg
    • Obesity class 3: 8.2 (9.2) kg
  • Total significant newborn morbidity: 8.8%
    • Lowest prevalence of morbidity: women in the normal weight BMI class 8.0%
    • Highest prevalence: women with class 3 obesity 12.4%
  • Total infant mortality within 1 year of birth: 0.34%
    • Lowest prevalence: women in normal weight class 0.28%
    • Highest prevalence: women with class 3 obesity: 0.58%
  • Optimal GWG ranges
    • Underweight and normal weight: 12.0 to <24.0 kg
    • Overweight: 10.0 to <20.0 kg
    • Class 1 obesity: 8.0 to <16.0 kg
    • Class 2 obesity: 6.0 to <16.0 kg
    • Class 3 obesity: 6.0 to <10.0 kg
  • Absolute risks of infant morbidity and mortality were lowest in the middle groups of GWG (U-shaped pattern)
    • Infant morbidity most prevalent in the lowest GWG groups among
      • Underweight <8 kg GWG: 14.7%
      • Normal weight women <0 kg GWG: 16.6%
    • Infant morbidity most prevalent in the highest GWG groups among
      • Obesity class 1 ≥30 kg GWG: 15.2%
      • Obesity class 2 ≥20 kg GWG: 13.7%
      • Obesity class 3 ≥20 kg GWG: 17.4%
  • Infant mortality
    • Most prevalent in the lowest GWG groups
    • Remained at low levels in middle and high GWG groups across BMI categories

CONCLUSION:

  • The lower bounds of the optimal GWG ranges are higher than the existing recommendations for
    • Overweight women: 10.0 vs 7.0 kg
    • Class 1 obesity: 8.0 vs 5.0 kg
    • Class 2 obesity: 6.0 vs 5.0 kg
    • Class 3 obesity: 6.0 vs 5.0 kg
  • Women with increasing BMI experienced decreasing rates of GWG
  • Inadequate GWG, even for women with obesity, was associated with increased risks of adverse infant outcome
  • The authors state

…ranges of optimal GWG generally decreased with BMI categories and the severity of obesity

Recommending a single GWG range (5.0-9.0 kg) for women with obesity may be of concern

… weight maintenance and weight loss should not be used as routine guidelines, even for women with obesity

  • Women should not be counseled to maintain or lose weight during pregnancy, regardless of BMI class

Learn More – Primary Sources:

Association of Gestational Weight Gain With Infant Morbidity and Mortality in the United States

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

RCT Results: Does Weight Loss Prior to Pregnancy Affect Gestational Weight Gain?
Can a Smartphone ‘Diet and Activity’ App Impact Gestational Weight Gain?
Is There an Association Between High or Low Weight Gain and Maternal and Infant Outcomes?
Practical obstetrics info for your women's healthcare practice
Recommended Weight Gain and Obesity Management in Pregnancy

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site